As an executive who fought to bring our first mAb biosimilar to market, I can tell you they're injected because your stomach acid would chew up these large, delicate proteins like a snack. Their names, ending in "-mab," are a complex code describing their source and target. The expense? Chala costly, because growing them in living cells is like maintaining a superstar's entourage—every step is pricey and patented. Frankly, seeing our production bills makes my salon AC loan feel like pocket change, but it's the same principle: you pay for the precise, fragile machinery that creates the comfort.
#fitness#health
Jump in to reply — no account needed.